<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55293">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01861132</url>
  </required_header>
  <id_info>
    <org_study_id>NexValid13</org_study_id>
    <nct_id>NCT01861132</nct_id>
  </id_info>
  <brief_title>Validation of a Non-invasive Hemodynamic Monitor (NexFin) in Pregnant Women</brief_title>
  <official_title>Validation of Non-invasive Monitoring of Blood Pressure and Cardiac Output in Healthy Pregnant Women During Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway: Data Protection Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive
      monitoring devices are desirable, but until now, no equipment has proven validity. This
      study aims at validating the non-invasive monitoring device NexFin (second generation
      Finometer) in pregnant women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive
      measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO
      Plus. Both comparison of absolute values and the two different devices trending abilities
      will be analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of beat-to-beat data</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparing beat-to-beat data of cardiac output</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Hemodynamic Changes in Pregnancy</condition>
  <arm_group>
    <arm_group_label>Healthy pregnant women</arm_group_label>
    <description>Healthy pregnant women for C-section under spinal anesthesia</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy singleton pregnancies at term scheduled for cesarean delivery under spinal
        anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy singleton pregnancies at term scheduled for cesarean delivery

        Exclusion Criteria:

          -  Twins, or multiple gestation, pre-eclampsia, gestational hypertension

          -  Reynaud phenomenon
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 10, 2014</lastchanged_date>
  <firstreceived_date>May 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy, cesarean delivery, blood pressure, cardiac output</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
